微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | -11.75% | -56.88% | -157.68% | 139/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | -4.56% | 3.39% | -200% | 135/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | -1.52% | 47.4% | 93.29% | 128/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -22.64% | 40.96% | -202.27% | 138/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | -7.49% | 38% | -58.69% | 132/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | -4.72% | -7.03% | -63.32% | 128/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | -2.89% | -256.22% | 92.46% | 133/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | -38.35% | -560.38% | -217.47% | 145/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | -12.08% | -217.62% | -173.92% | 133/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | -4.41% | -164.66% | -338.38% | 134/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 1.85% | -51.57% | -77.79% | 63/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 8.33% | 12.26% | -18.89% | 54/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 10.27% | 15.26% | 50.59% | 31/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 6.82% | 28.44% | 78.53% | 33/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 3.82% | 29.93% | -48.52% | 27/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 7.42% | -56.38% | -16.72% | 74/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 8.91% | 78.56% | 67.8% | 41/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 5.31% | 13.22% | 80.61% | 52/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 2.94% | -28.64% | -82.72% | 35/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 17.01% | 31.25% | 240.88% | 28/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 4.99% | -53.49% | 6.4% | 68/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 4.69% | -33.29% | 13.83% | 53/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 4.12% | 54.89% | -68.21% | 18/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 12.96% | -15.95% | 20.78% | 38/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 10.73% | -17.9% | 52.63% | 22/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 7.03% | -18.54% | 164.29% | 25/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 2.66% | -23.34% | -82.75% | 38/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 15.42% | -0.19% | 17.98% | 23/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 13.07% | -9.42% | 51.45% | 18/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 8.63% | -15.48% | 148.7% | 21/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 3.47% | -17.97% | -77.54% | 18/160 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 15.45% | -41.21% | 7.07% | 35/160 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 14.43% | 2% | 41.33% | 13/160 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 10.21% | 2% | 141.37% | 13/160 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 4.23% | 2% | -83.9% | 16/160 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 26.28% | 15.62% | 15.62% | 14/160 | 11.35% | 河化股份 | 19.29% | 行业排名> |